UF Researchers will begin evaluating whether hydroxychloroquine can prevent COVID-19 infections.
University of Florida College of Pharmacy researchers studying the safety of two classes of drugs touted as potential therapeutics for COVID-19 report mixed results.
UF researchers sifted through several thousand studies on human coronaviruses related to the novel SARS-CoV-2 which causes COVID-19, with the goal of learning from the past to help shape the future.
UF Health teamed up with UF Engineering to 3D print nasal swabs in an effort to mobilize campus and make COVID-19 testing more accessible.
Thirty UF faculty members and students answered the call when the state of Florida needed to drastically boost the number of epidemiologists working with health departments around the state.
A trio of interdisciplinary UF researchers are searching for genes that either hasten or thwart the growth of SARS-CoV-2 virus inside a human host. Their results may contribute to the search for a COVID-19 drug or therapeutic arsenal.
More than one-quarter of U.S. adults live with untreated tooth decay, with nearly half of adults over 30 showing signs of gum disease.
Patients with a vitamin D deficiency were four times more likely to be COVID-19 positive than those with a sufficient amount of the crucial vitamin.
Loss of smell occurs with the common cold and other viral infections of the nose and throat.
The number of American travelers who said domestic air travel should be avoided increased from 32% to 43% in three weeks, according to a new survey.
The question kept coming up: Why are some countries in the grip of COVID-19 while others appear less affected?
Hint: Rethink testing. New research shows how to reduce COVID-19 quarantine times by almost half simply by testing on exit from quarantine instead of entry.